Re: Minimally Invasive Therapy Using Intralesional OnabotulinumtoxinA in Peyronie's Disease

被引：0
作者：
Safarinejad, Mohammad Reza [1 ,2 ]
机构：
[1] Clin Ctr Urol Dis Diag, Tehran, Iran
[2] Private Clin Specializing Urol & Androl Genet, Tehran, Iran
来源：
UROLOGY JOURNAL | 2015年 / 12卷 / 02期
关键词：
DOUBLE-BLIND; PLACEBO; MANAGEMENT; EFFICACY; SAFETY; GUIDELINES; MEN;
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2111 / 2113
页数：3
相关论文
共 21 条
[1]  
Allergan Inc, 2013, BOTOX ONABOTULINUMTO
[2]   A Population-Based Study of Peyronie's Disease: Prevalence and Treatment Patterns in the United States [J].
DiBenedetti, Dana Britt ;
Nguyen, Dat ;
Zografos, Laurie ;
Ziemiecki, Ryan ;
Zhou, Xiaolei .
ADVANCES IN UROLOGY, 2011, 2011
[3]   Peyronie's disease in diabetic patients being screened for erectile dysfunction [J].
El-Sakka, AI ;
Tayeb, KA .
JOURNAL OF UROLOGY, 2005, 174 (03) :1026-1030
[4]   COLLAGENASE VERSUS PLACEBO IN THE TREATMENT OF PEYRONIES DISEASE - A DOUBLE-BLIND-STUDY [J].
GELBARD, MK ;
JAMES, K ;
RIACH, P ;
DOREY, F .
JOURNAL OF UROLOGY, 1993, 149 (01) :56-58
[5]   Current status and new developments in Peyronie's disease: medical, minimally invasive and surgical treatment options [J].
Gur, Serap ;
Limin, Ma ;
Hellstrom, Wayne J. G. .
EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (06) :931-944
[6]   EAU Guidelines on Penile Curvature [J].
Hatzimouratidis, Konstantinos ;
Eardley, Ian ;
Giuliano, Francois ;
Hatzichristou, Dimitrios ;
Moncada, Ignacio ;
Salonia, Andrea ;
Vardi, Yoram ;
Wespes, Eric .
EUROPEAN UROLOGY, 2012, 62 (03) :543-552
[7]   Effects of Botulinum Toxin A on Patient-Specific Keloid Fibroblasts In Vitro [J].
Haubner, Frank ;
Leyh, Michaela ;
Ohmann, Elisabeth ;
Sadick, Haneen ;
Gassner, Holger G. .
LARYNGOSCOPE, 2014, 124 (06) :1344-1351
[8]   Minimally invasive treatment of Peyronie's disease: evidence-based progress [J].
Jordan, Gerald H. ;
Carson, Culley C. ;
Lipshultz, Larry I. .
BJU INTERNATIONAL, 2014, 114 (01) :16-24
[9]   Intralesional interferon-alpha-2b for the treatment of Peyronie's disease [J].
Lacy, GL ;
Adams, DM ;
Hellstrom, WJG .
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2002, 14 (05) :336-339
[10]   Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening [J].
Mulhall, JP ;
Creech, SD ;
Boorjian, SA ;
Ghaly, S ;
Kim, ED ;
Moty, A ;
Davis, R ;
Hellstrom, W .
JOURNAL OF UROLOGY, 2004, 171 (06) :2350-2353
123